Literature DB >> 2047885

Small-duct primary sclerosing cholangitis.

J Ludwig1.   

Abstract

Current evidence suggests that PSC may affect the entire biliary system from interlobular bile ducts to the ampulla of Vater. If the affected bile ducts are too small for cholangiographic identification, the best designation for the condition is small-duct PSC; cholangiographically identifiable duct changes are the hallmark of large-duct PSC. The term "small-duct PSC" should replace the name pericholangitis because that designation lacks a clear definition. Small-duct PSC may occur in combination with large-duct PSC or it may occur alone. The clinical course of patients with PSC depends on the hepatic changes related to small-duct PSC, not primarily on the classic large-duct disease. Therefore the features of small-duct PSC and its complications are used to determine the disease stages of PSC. The incidence of small-duct PSC still is not known and the natural history as well as the pathogenesis of the condition remains obscure. Nevertheless, the role of small-duct disease in the syndrome of PSC has come into focus and the themes for future studies are apparent. Work should commence.

Entities:  

Mesh:

Year:  1991        PMID: 2047885     DOI: 10.1055/s-2008-1040417

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  22 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis.

Authors:  Motoko Sasaki; Masami Miyakoshi; Yasunori Sato; Yasuni Nakanuma
Journal:  Dig Dis Sci       Date:  2013-11-02       Impact factor: 3.199

3.  Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.

Authors:  A K Singal; C M Stanca; V Clark; L Dixon; C Levy; J A Odin; M I Fiel; S L Friedman; N Bach
Journal:  Hepatol Int       Date:  2011-03-11       Impact factor: 6.047

4.  Autophagy may precede cellular senescence of bile ductular cells in ductular reaction in primary biliary cirrhosis.

Authors:  Motoko Sasaki; Masami Miyakoshi; Yasunori Sato; Yasuni Nakanuma
Journal:  Dig Dis Sci       Date:  2011-10-12       Impact factor: 3.199

5.  Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis.

Authors:  Motoko Sasaki; Hiroko Ikeda; Yasunori Sato; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  Standardized reporting of histological diagnoses for non-neoplastic liver conditions in needle biopsies.

Authors:  M p Foschini; F Sarti; R E Dina; G Giuliani-Picari; P R Dal Monte; V Eusebi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

8.  Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.

Authors:  Rajan Kochar; Moises I Nevah; Frank J Lukens; Michael B Fallon; Victor I Machicao
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

9.  Small-duct primary sclerosing cholangitis. A single-center seven-year experience.

Authors:  Nikolaos L Nikolaidis; Olga I Giouleme; Konstantinos A Tziomalos; Kalliopi Patsiaoura; Eirini Kazantzidou; Anastasios D Voutsas; Themistoklis Vassiliadis; Nikolaos P Eugenidis
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 10.  Glucocorticosteroids for primary sclerosing cholangitis.

Authors:  Vanja Giljaca; Goran Poropat; Davor Stimac; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.